The top drug safety agencies in the U.S. and Europe have raised concerns about the risks associated with codeine in children’s cold-and-cough medicine. This month, the U.S. Food and Drug Administration (FDA) announced it is investigating the safety of codeine-containing cold-and-cough medicine for children younger than 18 due to the risk of potentially serious side effects. These can include slowed … Read More
Research reveals significant impact of drug-gene and drug-drug-gene interactions
Why do some patients react differently to the same drug? A study using data analyzed by the YouScript Personalized Prescribing Software has quantified the role genotypes may play in causing adverse drug reactions. The research, published in the journal Pharmacogenomics, showed that a combined 33.9 percent of all potential clinically significant drug interactions were due to drug-gene and drug-drug-gene interactions. These potential … Read More
More older Americans have chronic conditions compared to foreign counterparts, survey finds
An international survey of more than 10,000 adults age 65 or older has found that more Americans had multiple chronic conditions and took four or more prescription drugs than their age mates in 10 other countries. The survey, the results of which were published in a paper in the December issue of the journal Health Affairs, found that 68 percent … Read More
Genelex honored in 2014 Tech Impact Awards
Genelex’s progress toward eliminating adverse drug events has been honored by Seattle Business magazine with a 2014 Tech Impact Award. At the September 18 awards event, Genelex was given the silver award in the health category of the magazine’s 2014 Tech Impact Awards. Genelex joins both small and large tech luminaries, including Microsoft and T-Mobile, in being recognized as … Read More